Detalles de la búsqueda
1.
Cerebral protection in left atrial appendage closure in the presence of appendage thrombosis.
Catheter Cardiovasc Interv
; 97(3): 511-515, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32808741
2.
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations.
Catheter Cardiovasc Interv
; 97(2): E227-E236, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438488
3.
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries.
Am Heart J
; 220: 108-115, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31809991
4.
Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.
Catheter Cardiovasc Interv
; 96(3): E248-E256, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012453
5.
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes.
Catheter Cardiovasc Interv
; 96(1): 1-9, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31860158
6.
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study).
BMC Cardiovasc Disord
; 20(1): 225, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414330
7.
Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlled.
Int J Cardiol
; 396: 131428, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37820779
8.
In-hospital outcomes in nonagenarian patients undergoing primary percutaneous coronary intervention.
Minerva Cardiol Angiol
; 71(5): 590-598, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36475546
9.
OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCT.
Minerva Cardiol Angiol
; 71(4): 431-437, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36847434
10.
Incidence trends and long-term outcomes of myocardial infarction in young adults: Does gender matter?
Int J Cardiol
; 357: 134-139, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35301075
11.
Impact of lipid-lowering therapies on cardiovascular outcomes according to coronary artery calcium score. A systematic review and meta-analysis.
Rev Esp Cardiol (Engl Ed)
; 75(6): 506-514, 2022 Jun.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-34483065
12.
Impact of stent thickness on clinical outcomes in small vessel and bifurcation lesions: a RAIN-CARDIOGROUP VII sub-study.
J Cardiovasc Med (Hagerstown)
; 22(1): 20-25, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32740419
13.
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry.
Minerva Cardiol Angiol
; 69(4): 408-416, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34137238
14.
Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.
J Invasive Cardiol
; 33(11): E890-E899, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735352
15.
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting.
J Invasive Cardiol
; 32(9): 342-346, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32568097
16.
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries.
Am J Cardiovasc Drugs
; 20(3): 259-269, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31586336
17.
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.
Eur Heart J Cardiovasc Pharmacother
; 6(1): 31-42, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31511896
18.
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
Eur J Prev Cardiol
; 27(7): 696-705, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30862233
19.
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations.
Am J Cardiol
; 125(4): 491-499, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31889527
20.
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor.
Int J Cardiol
; 301: 200-206, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31785951